Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Evolve Telemed vs MyFastRx

Evolve Telemed
Graded #379

Lower grade

vs+9.499999999999993
MyFastRx
Graded #161

Higher grade

The verdict

MyFastRx takes it — 67.6/100 to 58.1/100.

MyFastRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MyFastRx is a cash-pay compounded-GLP-1 platform built around fast approval and discounted multi-month bundles.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMyFastRx +31
45
76
Dose & formulationMyFastRx +19
53
72
Clinical oversightEvolve Telemed +17
83
66
Labs & monitoringEven
52
52
FulfillmentMyFastRx +21
62
83
Contract termsEvolve Telemed +14
55
41
Evolve Telemed · left barMyFastRx · right bar

The numbers

MetricEvolve TelemedMyFastRx
WeighScore58.1/10067.6/100
GradeCC
Scorecard rank#379#161
SemaglutideNot disclosed$169/mo
TirzepatideNot disclosed$249/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Evolve Telemed

Graded #379 · C

Strengths

  • Established hormone- and peptide-optimization brand with board-certified specialists and a physician-plus-care-specialist support model
  • Compounded GLP-1 (semaglutide) weight care offered alongside TRT, menopause/BHRT, thyroid and sexual-wellness programs in one practice
  • Coordinated couples care plans plus dedicated men's and women's tracks
  • Free consultation to start, with published press, blog and FAQ resources

Where it loses points

  • No GLP-1 pricing published — cost is only revealed after a consultation, so you can't compare value upfront
  • Doesn't list the states it serves or name its compounding pharmacies
  • Weight loss is one of many verticals, not a dedicated GLP-1-first program
  • Tirzepatide availability isn't confirmed on the site; only compounded semaglutide is referenced
  • Not shown on our price-ranked /best lists because no pricing is disclosed
MyFastRx

Graded #161 · C

Strengths

  • Aggressive 12-month bundle pricing — $99/mo semaglutide, $149/mo tirzepatide
  • LegitScript certified
  • All doses priced the same — no cost escalation as you titrate up
  • First-month promo discount lowers the trial barrier

Where it loses points

  • States served not disclosed — only 'multiple states' / 'licensed U.S. providers'
  • Corporate address and medical director not published
  • Pharmacy partner not named — only 'state-licensed pharmacies'
  • Cash-pay only — no insurance billing
  • Bundle savings require a large upfront commitment (12 months billed at once)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard